Be a part of
Breakthrough
Research

This is a research study looking for people between the ages of 18 to 49 investigating a new mRNA vaccine designed to prevent against Respiratory syncytial virus (RSV).

This study is researching the effects of a medication on the cardiovascular outcomes and kidney function in adults living with obesity. Living with excess weight or obesity can increase your risk of chronic health conditions, such as cardiovascular disease and kidney disease.  

Canopy Clinical Wollongong has launched a new respiratory virus vaccine research program for local Illawarra residents between the ages of 18 and 45.

This study is researching an investigational influenza vaccine for people aged 65 and older. The vaccine aims to be more effective in preventing influenza A and B in comparison to current publicly available influenza vaccines.

This study is investigating the effect of a potential new medication designed to lower triglyceride levels in people with hypertriglyceridemia.

This is a research study investigating a potential new treatment for atherosclerosis, a chronic heart disease.

This research study is investigating a new potential treatment for Venous Leg Ulcers (VLUs), a clear gel containing an experimental drug that is applied directly to the VLU; compared to a control placebo gel treatment.

This study is investigating the use of a new medication that is a combination of two previously approved treatments for hypertension to target the CNS physiological stress system for patients with panic disorder.

This research study is investigating the safety and effects of a new antiviral medication to suppress recurrent genital herpes in participants living with recurrent genital herpes.

Canopy Clinical has launched a suite of weight-management related studies. Register your interest in participating today.